These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11092972)

  • 1. A novel "Nihon" rat model of a Mendelian dominantly inherited renal cell carcinoma.
    Okimoto K; Kouchi M; Kikawa E; Toyosawa K; Koujitani T; Tanaka K; Matsuoka N; Sakurai J; Hino O
    Jpn J Cancer Res; 2000 Nov; 91(11):1096-9. PubMed ID: 11092972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic mutation of the tuberous sclerosis (Tsc2) tumor suppressor gene in chemically induced rat renal carcinoma cell.
    Urakami S; Tokuzen R; Tsuda H; Igawa M; Hino O
    J Urol; 1997 Jul; 158(1):275-8. PubMed ID: 9186374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal cell carcinoma development in the rat independent of alterations at the VHL gene locus.
    Walker C; Ahn YT; Everitt J; Yuan X
    Mol Carcinog; 1996 Feb; 15(2):154-61. PubMed ID: 8599582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational analysis of the von hippel lindau gene in clear cell renal carcinomas from tuberous sclerosis complex patients.
    Duffy K; Al-Saleem T; Karbowniczek M; Ewalt D; Prowse AH; Henske EP
    Mod Pathol; 2002 Mar; 15(3):205-10. PubMed ID: 11904337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial clear cell renal cell carcinoma (FCRC): clinical features and mutation analysis of the VHL, MET, and CUL2 candidate genes.
    Woodward ER; Clifford SC; Astuti D; Affara NA; Maher ER
    J Med Genet; 2000 May; 37(5):348-53. PubMed ID: 10807693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural history of the Nihon rat model of BHD.
    Okimoto K; Kouchi M; Matsumoto I; Sakurai J; Kobayashi T; Hino O
    Curr Mol Med; 2004 Dec; 4(8):887-93. PubMed ID: 15579036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VHL alterations in human clear cell renal cell carcinoma: association with advanced tumor stage and a novel hot spot mutation.
    Brauch H; Weirich G; Brieger J; Glavac D; Rödl H; Eichinger M; Feurer M; Weidt E; Puranakanitstha C; Neuhaus C; Pomer S; Brenner W; Schirmacher P; Störkel S; Rotter M; Masera A; Gugeler N; Decker HJ
    Cancer Res; 2000 Apr; 60(7):1942-8. PubMed ID: 10766184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of high-grade renal cell carcinomas in rats independently of somatic mutations in the Tsc2 and VHL tumor suppressor genes.
    Toyokuni S; Okada K; Kondo S; Nishioka H; Tanaka T; Nishiyama Y; Hino O; Hiai H
    Jpn J Cancer Res; 1998 Aug; 89(8):814-20. PubMed ID: 9765616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The genetic basis of cancer of the kidney.
    Linehan WM; Walther MM; Zbar B
    J Urol; 2003 Dec; 170(6 Pt 1):2163-72. PubMed ID: 14634372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A germ-line insertion in the Birt-Hogg-Dubé (BHD) gene gives rise to the Nihon rat model of inherited renal cancer.
    Okimoto K; Sakurai J; Kobayashi T; Mitani H; Hirayama Y; Nickerson ML; Warren MB; Zbar B; Schmidt LS; Hino O
    Proc Natl Acad Sci U S A; 2004 Feb; 101(7):2023-7. PubMed ID: 14769940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal carcinogenesis: genotype, phenotype and dramatype.
    Hino O; Kobayashi T; Momose S; Kikuchi Y; Adachi H; Okimoto K
    Cancer Sci; 2003 Feb; 94(2):142-7. PubMed ID: 12708488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel-Lindau disease patients.
    Lubensky IA; Gnarra JR; Bertheau P; Walther MM; Linehan WM; Zhuang Z
    Am J Pathol; 1996 Dec; 149(6):2089-94. PubMed ID: 8952541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [VHL gene and TSC 2 gene].
    Hino O
    Gan To Kagaku Ryoho; 1997 Sep; 24(11):1386-91. PubMed ID: 9309130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular detection of von Hippel-Lindau gene mutations in urine and lymph node samples in patients with renal cell carcinoma: potential biomarkers for early diagnosis and postoperative metastatic status.
    Ashida S; Furihata M; Tanimura M; Sugita O; Yamashita M; Miura T; Moriyama M; Shuin T
    J Urol; 2003 Jun; 169(6):2089-93. PubMed ID: 12771725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TSC2 gene mutant (Eker) rat model of a Mendelian dominantly inherited cancer.
    Hino O; Fukuda T; Satake N; Kobayashi T; Honda S; Orimoto K; Yamashita Y; Kikuchi Y
    Prog Exp Tumor Res; 1999; 35():95-108. PubMed ID: 10377754
    [No Abstract]   [Full Text] [Related]  

  • 16. TSC1 and TSC2 gene mutations in human kidney tumors.
    Kajino K; Hino O
    Contrib Nephrol; 1999; 128():45-50. PubMed ID: 10597376
    [No Abstract]   [Full Text] [Related]  

  • 17. Von Hippel-Lindau disease and sporadic renal cell carcinoma.
    Zbar B
    Cancer Surv; 1995; 25():219-32. PubMed ID: 8718521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor-B and vascular endothelial growth factor-C expression in renal cell carcinomas: regulation by the von Hippel-Lindau gene and hypoxia.
    Gunningham SP; Currie MJ; Han C; Turner K; Scott PA; Robinson BA; Harris AL; Fox SB
    Cancer Res; 2001 Apr; 61(7):3206-11. PubMed ID: 11306510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of HNF1alpha function in human renal cell carcinoma: frequent mutations in the VHL gene but not the HNF1alpha gene.
    Lemm I; Lingott A; Pogge v Strandmann E; Zoidl C; Bulman MP; Hattersley AT; Schulz WA; Ebert T; Ryffel GU
    Mol Carcinog; 1999 Apr; 24(4):305-14. PubMed ID: 10326868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of a modifier gene(s) affecting early renal carcinogenesis in the Tsc2 mutant (Eker) rat model.
    Kikuchi Y; Sudo A; Mitani H; Hino O
    Int J Oncol; 2004 Jan; 24(1):75-80. PubMed ID: 14654943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.